jetcityimage/iStock Editorial via Getty Images AmerisourceBergen Drug, now known as Cencora (NYSE:COR) awarded an estimated ~$2B modification extending the third two-year six-month option period of a...
Source Linkjetcityimage/iStock Editorial via Getty Images AmerisourceBergen Drug, now known as Cencora (NYSE:COR) awarded an estimated ~$2B modification extending the third two-year six-month option period of a...
Source Link
Comments